92 related articles for article (PubMed ID: 22007493)
1. [Pharmacokinetics and relative bioavailability of neostigmine bromide sustained-release tablets].
Xiong HR; Tan QY; Liu BL; Luo W; Zhang JQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):657-60. PubMed ID: 22007493
[TBL] [Abstract][Full Text] [Related]
2. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers].
Li T; Pang Y; Wang Z; Jia Y; Cheng Q; Sun J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):541-3. PubMed ID: 12910715
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between in vitro release and in vivo absorption of sustained-releasing tablets of neostigmine bromide].
Luo W; Tan QY; Xiong HR; Zhao CJ; Zhang JQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 44(1):80-3. PubMed ID: 23600216
[TBL] [Abstract][Full Text] [Related]
5. [Bioequivalence of pyridostigmine bromide dispersible tablets in rabbits].
Wang H; Wang H; Tan QY; Zhang L; Cheng XG; Zhang JQ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1778-80. PubMed ID: 22027790
[TBL] [Abstract][Full Text] [Related]
6. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
7. [Determination of vitexin-rhamnoside in Beagle dog plasma and preliminary pharmacokinetics of Yixintong sustained release tablets].
Qu L; Zheng HS; Feng NP; Li SM
Zhongguo Zhong Yao Za Zhi; 2008 May; 33(10):1168-70. PubMed ID: 18720869
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of ginkgolides sustained-release tablet].
Jin M; Guo Q; Sun X; Zhang X; Lv Y; Xiao W
Zhongguo Zhong Yao Za Zhi; 2011 Apr; 36(8):1011-4. PubMed ID: 21809574
[TBL] [Abstract][Full Text] [Related]
9. [Toxicokinetics of paraquat in rabbits].
Kan X; Zhang XY; Dong J; Li WS; Hu GX; Lu ZQ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Oct; 28(10):756-9. PubMed ID: 21126428
[TBL] [Abstract][Full Text] [Related]
10. Preparation and pharmacokinetics in beagle dogs of once-a-day tetramethylpyrazine phosphate sustained-release pellets.
Yanyu X; Qineng P; Zhigui S; Hongying L; Jiangxiu N
Drug Dev Ind Pharm; 2012 Mar; 38(3):301-6. PubMed ID: 21851289
[TBL] [Abstract][Full Text] [Related]
11. [Bioequivalence of enteric coated tablet of Zhengqing Fengtongning].
Zhang SH; Zhou YD; He HX
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(6):683-5. PubMed ID: 18590201
[TBL] [Abstract][Full Text] [Related]
12. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic study of a new chewing gum dextromethorphan delivery system].
Liu J; Tan QY; Liu BL; Xu ML; Zhao CJ; Zhang JQ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):103-7. PubMed ID: 21269969
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
15. Comparison of pharmacokinetics in beagle dogs of nimesulide bilayer tablets with dispersible tablets.
Yang MY; Wang YL; Guo JF; Shan L; Li Y; Bai XQ; Fan YZ; Gao CS
Drug Dev Ind Pharm; 2013 Jan; 39(1):156-61. PubMed ID: 22397600
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of two oral bezafibrate preparations.
Cadorniga R; Herrero R; Pastoriza P; Molina IT; Gutierrez JA; Iglesias JJ
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():261-7. PubMed ID: 1820889
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of intranasal neostigmine: comparison with intravenous route.
Broggini M; Benvenuti C; Botta V; Fossati A; Valenti M
Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):193-8. PubMed ID: 2051843
[TBL] [Abstract][Full Text] [Related]
18. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs].
Chen XX; Yuan S; Li G; Liang YY; Zhou X; Xie CS; Long CF
Zhong Yao Cai; 2011 May; 34(5):750-3. PubMed ID: 21954564
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.
Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E
Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
